首页 > 市场调查报告书 > 医疗设备

体外诊断癌症癌症诊断

市场调查报告书

商品编码

1609804

2025-2033 年日本癌症诊断市场报告（按产品、技术、应用、最终用户和地区划分）

Japan Cancer Diagnostics Market Report by Product, Technology, Application, End User, and Region 2025-2033

出版日期: 2024年12月05日 | 出版商:

IMARC | 英文 120 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2024 年日本癌症诊断市场IMARC Group达到 13 亿美元。由于生活方式的改变和遗传因素，癌症发病率不断上升，以及改善患者护理的诊断方法的发展是市场成长的主要驱动力。

癌症诊断涉及个别癌症的识别和表征，包括各种方法和技术，如磁振造影 (MRI)、X 光以及血液、组织和遗传样本的实验室检查。这些诊断工具使医疗保健专家能够精确检测和评估体内的癌症状况，从而促进准确的评估。此外，它们还使医疗保健提供者能够根据疾病的独特属性量身定制治疗方法，从而优化患者的治疗结果。这种方法有助于完善治疗选择并制定个人化的治疗方法。

日本癌症诊断市场趋势：

在日本的癌症诊断市场，由于生活方式的改变、环境影响、人口老化和遗传倾向等多种因素，癌症病例显着激增。累积的基因突变和长期暴露于潜在致癌物质导致民众癌症发生率上升。此外，不健康的生活方式选择，例如不良的饮食习惯和有限的身体活动，也会增加罹患癌症的风险。值得注意的是，人们越来越倾向于早期检测作为提高癌症治疗效果的手段。对准确及时的癌症诊断以预防併发症的需求不断增加，进一步推动了市场的扩张。此外，医疗保健服务可近性的改善在促进日本市场成长方面发挥关键作用。由于消费者对早期癌症检测重要性的认识不断提高，日本癌症诊断市场正在进一步成长。人们正在积极进行常规筛检和诊断检查，以主动监测自己的健康状况。此外，医疗保健提供者和组织正在进行广泛的宣传活动，旨在教育公众早期介入的优势，从而鼓励积极主动的就医行为。此外，早期检测不仅可以提高治疗效果，还可以减轻与晚期癌症相关的整体医疗负担。各国监管机构和医疗机构正在实施无障碍筛检计划，并强调及时癌症诊断的重要性。这些倡议正在激励个人定期接受癌症筛检，预计这将在预测期内推动区域市场的发展。

日本癌症诊断市场细分：

产品见解：

耗材
抗体
试剂盒和试剂
探头
其他的
仪器仪表
病理学仪器
影像仪器
切片仪器

技术见解：

体外诊断测试
聚合酶炼式反应 (PCR)
原位杂交 (ISH)
免疫组织化学 (IHC)
新一代定序 (NGS)
微阵列
流式细胞仪
免疫测定
其他的
影像学
磁振造影 (MRI)
电脑断层扫描 (CT)
正子断层扫描 (PET)
乳房X光检查
超音波
切片技术

应用见解：

乳癌
肺癌
大肠直肠癌
黑色素瘤
其他的

最终使用者见解：

医院和诊所
诊断实验室
其他的

竞争格局：

市场研究报告也对市场竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

到目前为止，日本癌症诊断市场的表现如何？
COVID-19 对日本癌症诊断市场有何影响？
日本癌症诊断市场依产品划分是怎样的？
日本癌症诊断市场在技术上的分化是什么？
日本癌症诊断市场在应用上的细分如何？
日本癌症诊断市场以最终用户划分是怎样的？
日本癌症诊断市场价值链的各个阶段是什么？
日本癌症诊断的关键驱动因素和挑战是什么？
日本癌症诊断市场的结构如何？
日本癌症诊断市场的竞争程度如何？

本报告回答的关键问题：

到目前为止，日本癌症诊断市场的表现如何？
COVID-19 对日本癌症诊断市场有何影响？
日本癌症诊断市场依产品划分是怎样的？
日本癌症诊断市场在技术上的分化是什么？
日本癌症诊断市场在应用上的细分如何？
日本癌症诊断市场以最终用户划分是怎样的？
日本癌症诊断市场价值链的各个阶段是什么？
日本癌症诊断的关键驱动因素和挑战是什么？
日本癌症诊断市场的结构如何？
日本癌症诊断市场的竞争程度如何？

耗材
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场区隔
  - 抗体
  - 试剂盒和试剂
  - 探头
  - 其他的
- 市场预测（2025-2033）
仪器仪表
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场区隔
  - 病理学仪器
  - 影像仪器
  - 切片仪器
- 市场预测（2025-2033）

第 7 章：日本癌症诊断市场 - 细分：技术

体外诊断测试
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场区隔
  - 聚合酶炼式反应 (PCR)
  - 原位杂交 (ISH)
  - 免疫组织化学 (IHC)
  - 新一代定序 (NGS)
  - 微阵列
  - 流式细胞仪
  - 免疫测定
  - 其他的
- 市场预测（2025-2033）
影像学
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场区隔
  - 磁振造影 (MRI)
  - 电脑断层扫描 (CT)
  - 正子断层扫描 (PET)
  - 乳房X光检查
  - 超音波
- 2025-2033 年市场预测
切片技术
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）

第 8 章：日本癌症诊断市场 - 细分：按应用分类

乳癌
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
肺癌
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
大肠直肠癌
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
黑色素瘤
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
其他的
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）

第 9 章：日本癌症诊断市场 - 细分：按最终用户划分

医院和诊所
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
诊断实验室
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
其他的
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）

第 10 章：日本癌症诊断市场 - 竞争格局

概述
市场结构
市场参与者定位
最佳制胜策略
竞争仪表板
公司评估象限

第 11 章：关键参与者简介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 12 章：日本癌症诊断市场 - 产业分析

驱动因素、限制因素和机会
- 概述
- 司机
- 限制
- 机会
波特五力分析
- 概述
- 买家的议价能力
- 供应商的议价能力
- 竞争程度
- 新进入者的威胁
- 替代品的威胁
价值链分析

第 13 章：附录

简介目录

Product Code: SR112024A16297

Japan cancer diagnostics market size reached USD 1.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.6 Billion by 2033, exhibiting a growth rate (CAGR) of 12.2% during 2025-2033. The rising incidence of cancer, due to lifestyle shifts and genetic factors, and the development of diagnostic methods to improve patient care are among the primary drivers of the market growth.

Cancer diagnostics involve the identification and characterization of cancer in individuals, encompassing various methods and technologies like magnetic resonance imaging (MRI), X-rays, and laboratory examinations of blood, tissue, and genetic samples. These diagnostic tools enable healthcare experts to precisely detect and evaluate cancerous conditions within the body, facilitating accurate assessments. Additionally, they empower healthcare providers to customize treatments based on the unique attributes of the disease, thereby optimizing patient outcomes. This approach aids in refining treatment choices and crafting personalized therapeutic approaches.

Japan Cancer Diagnostics Market Trends:

In Japan's cancer diagnostics market, there is a notable surge in cancer cases driven by a multitude of factors, including shifts in lifestyle patterns, environmental influences, an aging population, and genetic predisposition. Accumulated genetic mutations and prolonged exposure to potential carcinogens have resulted in a rising incidence of cancer among the populace. Furthermore, unhealthy lifestyle choices such as poor dietary habits and limited physical activity are contributing to an increased risk of cancer. Notably, there is a growing inclination towards early detection as a means to enhance the effectiveness of cancer treatment. The heightened demand for precise and timely cancer diagnosis to prevent complications further fuels market expansion. Additionally, the improved accessibility to healthcare services plays a pivotal role in boosting market growth within Japan. The Japan cancer diagnostics market is further experiencing growth driven by an increasing awareness among consumers regarding the significance of early cancer detection. People are actively pursuing routine screenings and diagnostic examinations to proactively monitor their health status. Additionally, healthcare providers and organizations are conducting extensive awareness campaigns aimed at educating the public about the advantages of early intervention, thereby encouraging proactive healthcare-seeking behavior. Furthermore, early detection not only enhances treatment outcomes but also reduces the overall healthcare burden associated with advanced-stage cancer. Regulatory authorities and healthcare institutions in various countries are implementing accessible screening programs and emphasizing the importance of timely cancer diagnosis. These initiatives are motivating individuals to undergo regular cancer screenings, which is expected to fuel the regional market over the forecasted period.

Japan Cancer Diagnostics Market Segmentation:

Product Insights:

Consumables
Antibodies
Kits and Reagents
Probes
Others
Instruments
Pathology-based Instruments
Imaging Instruments
Biopsy Instruments

Technology Insights:

IVD Testing
Polymerase Chain Reaction (PCR)
In Situ Hybridization (ISH)
Immunohistochemistry (IHC)
Next-generation Sequencing (NGS)
Microarrays
Flow Cytometry
Immunoassays
Others
Imaging
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
Positron Emission Tomography (PET)
Mammography
Ultrasound
Biopsy Technique

Application Insights:

Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Others

End User Insights:

Hospitals and Clinics
Diagnostic Laboratories
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan cancer diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan cancer diagnostics market?
What is the breakup of the Japan cancer diagnostics market on the basis of product?
What is the breakup of the Japan cancer diagnostics market on the basis of technology?
What is the breakup of the Japan cancer diagnostics market on the basis of application?
What is the breakup of the Japan cancer diagnostics market on the basis of end user?
What are the various stages in the value chain of the Japan cancer diagnostics market?
What are the key driving factors and challenges in the Japan cancer diagnostics?
What is the structure of the Japan cancer diagnostics market and who are the key players?
What is the degree of competition in the Japan cancer diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Cancer Diagnostics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Cancer Diagnostics Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Cancer Diagnostics Market - Breakup by Product

6.1 Consumables
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Antibodies
  - 6.1.3.2 Kits and Reagents
  - 6.1.3.3 Probes
  - 6.1.3.4 Others
- 6.1.4 Market Forecast (2025-2033)
6.2 Instruments
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Segmentation
  - 6.2.3.1 Pathology-based Instruments
  - 6.2.3.2 Imaging Instruments
  - 6.2.3.3 Biopsy Instruments
- 6.2.4 Market Forecast (2025-2033)

7 Japan Cancer Diagnostics Market - Breakup by Technology

7.1 IVD Testing
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Segmentation
  - 7.1.3.1 Polymerase Chain Reaction (PCR)
  - 7.1.3.2 In Situ Hybridization (ISH)
  - 7.1.3.3 Immunohistochemistry (IHC)
  - 7.1.3.4 Next-generation Sequencing (NGS)
  - 7.1.3.5 Microarrays
  - 7.1.3.6 Flow Cytometry
  - 7.1.3.7 Immunoassays
  - 7.1.3.8 Others
- 7.1.4 Market Forecast (2025-2033)
7.2 Imaging
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Segmentation
  - 7.2.3.1 Magnetic Resonance Imaging (MRI)
  - 7.2.3.2 Computed Tomography (CT)
  - 7.2.3.3 Positron Emission Tomography (PET)
  - 7.2.3.4 Mammography
  - 7.2.3.5 Ultrasound
- 7.2.4 Market Forecast 2025-2033
7.3 Biopsy Technique
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)

8 Japan Cancer Diagnostics Market - Breakup by Application

8.1 Breast Cancer
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Lung Cancer
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Colorectal Cancer
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Melanoma
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Others
- 8.5.1 Historical and Current Market Trends (2019-2024)
- 8.5.2 Market Forecast (2025-2033)

9 Japan Cancer Diagnostics Market - Breakup by End User

9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Diagnostic Laboratories
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Others
- 9.3.1 Historical and Current Market Trends (2019-2024)
- 9.3.2 Market Forecast (2025-2033)

10 Japan Cancer Diagnostics Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Cancer Diagnostics Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis